Immunovia AB
IMMNOV
Rang in Aktien
#34538
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Aktienkurs
$0.00739046
Marktkapitalisierung
$4.97M
Veränderung (1 Tag)
-3.69%
Veränderung (1 Jahr)
-78.59%
Land
SE
Handel Immunovia AB (IMMNOV)
Kategorie
Healthcare
Kursverlauf für Immunovia AB (IMMNOV)
Höchster Schlusskurs: $0.01 am 2026-10-01
Niedrigster Schlusskurs: $12.22 am 2018-01-01
Niedrigster Schlusskurs: $12.22 am 2018-01-01
Kursverlauf der Aktie von Immunovia AB von 2018 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -27.09% |
| 2025 | -57.69% |
| 2024 | -60.72% |
| 2023 | -94.55% |
| 2022 | -61.46% |
| 2021 | -45.87% |
| 2020 | -13.27% |
| 2019 | -8.33% |
| 2018 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $682.96 | 20.41% |
US
|
|
| $232.14 | 6.44% |
US
|
|
| $392.43 | 108.72% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $173.99 | 19.28% |
US
|
